Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Eutelsat (LSE:ETL) Launches EUR 670M Rights Issue to Support Capital Plan

Eutelsat Communications S.A. (LSE:ETL) has launched ashare capitalincrease withshareholders’ preferential subscription rights for approximately EUR 670M (the “Rights Issue”). The transaction follows the completion of EUR 828M reservedcapitalincreases in November 2025, which were subscribed by the French State via the Agence des Participations de …

Team Kalkine | 25 November 2025

UK fiscal strain amid global geopolitics and rate-cut doubts:

Macro Update:Britain heads into Wednesday’s budget with renewed pressure on finance minister Rachel Reeves, who is poised to announce another round of substantial tax hikes despite having vowed last year they would not be repeated. Confidence within the Labour Party and scrutiny from bond …

Team Kalkine | 25 November 2025

Trellus Health (LSE:TRLS) Secures USD 600k Loan from Mount Sinai to Extend Cash Runway

Trellus Health® plc (LSE:TRLS), a digital healthcare company delivering Trellus Elevate®, announced an unsecuredloanagreement with substantialshareholderIcahn School of Medicine at Mount Sinai (“Mount Sinai”) totaling USD 600,000. The Loan Note is structured to be non-interest bearing for six months, after which it will accrue …

Team Kalkine | 24 November 2025

Orcadian Energy (LSE: ORC) Gains Three-Year Extension on North Sea Pilot Licence

Orcadian Energy plc (LSE:ORCA) has received approval from the North Sea Transition Authority (NSTA) for a three-year extension of the Second Term of Pilot Licence P2244. The new licence expiry date is 1 December 2028. This extension provides additional time for the operator to …

Team Kalkine | 24 November 2025

SAAS Shares Plunge 30% as FY25 Forecast Misses Market Expectations

Microlise Group plc (LSE:SAAS) has provided an update on its trading for the year ending 31 December 2025. Based on year-to-date trading and the pipeline for the remainder of FY25, the Group now expects totalrevenuesto be below current market expectations, at not less than …

Team Kalkine | 24 November 2025

S4 Capital PLC (LSE:SFOR) Lowers 2025 Revenue Forecast by Nearly 10%

S4 Capital PLC (LSE:SFOR) has updated its 2025 financial outlook following the release of third quarter results and October financial performance. The company now anticipates like-for-like netrevenuefor 2025 to decline by just under 10% compared with previous forecasts. The reduction is attributed to lower …

Team Kalkine | 24 November 2025

M&C Saatchi (LSE:SAA) FY 2025 Revenue Falls 7% After US Shutdown; GBP 5m Buyback Planned

M&C Saatchi (LSE:SAA) has issued updated guidance for the twelve months ending 31 December 2025. Trading in the second half of the year was affected by the unprecedented US Government shutdown, which had a notable impact on the Company’s Issues specialism, a key contributor …

Team Kalkine | 24 November 2025

Ferrexpo Firestorm: Why FXPO Stock Rocketed 24% on the LSE?

Ferrexpo's principal assets are itsmines and processing plants in central Ukraine. Given its location and the ongoing legal disputes related to asset ownership andtax,FXPOis the definition of a headline-driven stock. This spike signals that, for a brief period, investor sentiment swung decisively to the …

Team Kalkine | 24 November 2025

ImmuPharma PLC (LSE:IMM) Pushes P140 Partnership to 2026, Cash Position Extends Into Q4

ImmuPharma PLC (LSE:IMM), a specialist drug discovery and development company, provided an update on its P140 partnership discussions. In a previous notification on 23 October 2025, the company indicated it had engaged with multiple potential partners, including several top ten global pharmaceutical companies, aiming …

Team Kalkine | 24 November 2025

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions